The Central Nervous System-Restricted Transcription Factor Olig2 Opposes p53 Responses to Genotoxic Damage in Neural Progenitors and Malignant Glioma
Shwetal Mehta(Barrow Neurological Institute), Charles D. Stiles(Dana-Farber Cancer Institute), Keith L. Ligon(Brigham and Women's Hospital), Diane Golebiowski(University of Massachusetts Chan Medical School), John A. Alberta, David H. Rowitch(Broad Institute), Cécile L. Maire(Dana-Farber Cancer Institute), Santosh Kesari(Cancer Institute (WIA)), Emmanuelle Huillard, Michael Kane(Howard Hughes Medical Institute), Matthew Theisen(Dana-Farber Cancer Institute)
Cited by 156
Related Papers
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor
|Cell|1983|2.3k
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k
Epidermal growth factor receptor and Ink4a/Arf
|Cancer Cell|2002|647
Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS
|Genes & Development|2009|632
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma
|Journal of Translational Medicine|2018|540